Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

Clover Health Investments, Corp's (NASDAQ:CLOV) stock attempted to bust through an upper resistance level at the $9.09 mark but rejected the level and wicked from it. The stock has attempted to break above the level on three separate occasions over the past eight trading days but failed.

Why Clover Health Could Be Setting Up To Pummel Shorts Again

Today, CLOV stock is once again in the crosshairs of investors not only as a short-squeeze play but also due to company-specific catalysts. The post CLOV Stock: 2 Big Reasons Clover Health Is Gaining Today appeared first on InvestorPlace.

CLOV Stock: 2 Big Reasons Clover Health Is Gaining Today

While it beat revenue estimates last quarter, there's still plenty that could keep CLOV stock stuck at single-digit prices. The post Even After Its Revenue Beat, Stay Away From Clover Stock appeared first on InvestorPlace.

Even After Its Revenue Beat, Stay Away From Clover Stock

Facing an SEC investigation and generating mounting losses, while recently reporting the departure of its CFO, Clover's issues make CLOV stock a sell. The post Clover Health Stock Is Covered in Red Flags appeared first on InvestorPlace.

Clover Health Stock Is Covered in Red Flags

NASHVILLE, Tenn.--(BUSINESS WIRE)-- #cancer--Thyme Care announces strategic partnership with Clover Health to support members navigating through their cancer journey

Thyme Care Announces Strategic Partnership with Clover Health to Support Members Navigating Through Their Cancer Journey

CLOV stock looks to be setting up for a short squeeze. But that runs the risk of papering over the obstacles that Clover Health needs to overcome.

Is the Juice Worth the Squeeze in Clover Health Investments Stock?

Complications abound, but they're not all bad.

3 Things About Clover Health That Smart Investors Know

Clover Health has been a disappointing situation all year long. And things went from bad to worse for CLOV stock following dour Q2 earnings.

Clover Health: Insurance Losses Lead to Anemic Stock Price

Off and on the price chart, the evidence continues to stress CLOV stock simply isn't a worthwhile investment for apes and other bulls. The post Don't Fall for the Ape's Banana Trick in Clover Health appeared first on InvestorPlace.

Don't Fall for the Ape's Banana Trick in Clover Health

NASHVILLE, Tenn., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), a technology company committed to improving health equity for America's underserved seniors, today announced that CEO Vivek Garipalli and President & CTO Andrew Toy will present at the 2021 Wells Fargo Virtual Healthcare Conference on Thursday, September 9, 2021, at 3:20 p.m. Eastern Time.

Clover Health to Present at the 2021 Wells Fargo Virtual Healthcare Conference on September 9, 2021

NASHVILLE, Tenn., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), (“Clover Health” or “the Company”), an innovative technology company committed to improving health equity for America's underserved seniors, today announced that the Company has extended the period during which the holders of the Company's public warrants may exercise such warrants to 5:00 p.m. New York City time on September 9, 2021 (the “New Redemption Date”). Over 90% of the public warrants have already been exercised, and the Company, in an act of good faith, has decided to change the redemption date for the public warrants in order to provide investors with additional time to exercise the remaining outstanding warrants.

Clover Health Investments, Corp. Announces Extension of Redemption Date for Outstanding Warrants

Alignment Healthcare may not be a meme stock, but there's a lot to like about its business and growth potential.

Like Clover Health? This Growth Stock Is an Even Better Buy

AMC Entertainment

GameStop

Workhorse Group

Meme stocks mania is not slowing down. In fact, GME and AMC stocks are rocketing upward today, and bringing others up in sympathy.

Meme Stocks Mania: What Happened With GME and AMC Stocks Today?

CLOV stock went public via a SPAC and ever since it became a meme stock, and things continue to not look good at all for these reasons. The post Clover Health Has Serious Fundamental Flaws and Struggling Business Plan appeared first on InvestorPlace.

Clover Health Has Serious Fundamental Flaws and Struggling Business Plan

Activist investor ValueAct Capital Management has amassed a position in Fiserv Inc., the parent company of Clover, and argued in an investor presentation that Clover could be worth $185 billion by 2024, Bloomberg reported. ValueAct is an activist investor that has bought positions in — and then pushed for change at — companies as big […]

Report: Activist Investor Sees Clover Worth $185B By 2024

Apple

Amazon

Alibaba

Corsair Gaming

Microsoft

NVIDIA

Tesla

Wish

As traders look to replicate the success of Wall Street Bets stocks, one data aggregator is compiling the most mentioned stocks on Reddit's forum.

These are the top 10 stocks Reddit's Wall Street Bets is talking about

Clover Health claims to be a data-driven Medicare Advantage provider, but every health insurer is a data-driven Medicare Advantage provider. The post Clover Health Stock Harbors More Weeds Than Daisies appeared first on InvestorPlace.

Clover Health Stock Harbors More Weeds Than Daisies

CLOV stock has been at the center of short squeeze mania. That's fine, but the positive financials provide other reasons to take a position.

Clover Health Stock Is at the Center of a Controversy, but It Still Can Move Higher

This once-popular short-squeeze gem has fallen on hard times.

Is Clover Health a Buy?

Struggling CLOV stock suddenly got a Q2 earnings reprieve but investors should think carefully before riding this momentum. The post Clover Health Investments Stock Is a Gamble on Two Different Fronts appeared first on InvestorPlace.

Clover Health Investments Stock Is a Gamble on Two Different Fronts

Fastly

SoFi Technologies

Teladoc

Markets are under pressure, and that leaves the door open for short-term opportunities. That said, here are our top stock trades for Tuesday.

4 Top Stock Trades for Tuesday: FSLY, SOFI, TDOC, CLOV

Paysafe

United Wholesale Mortgage

These are the 10 most popular stocks being talked about on Reddit's Wall Street Bets forum

Clover Health's results were unimpressive in the second quarter. CLOV stock is worth just $6.81 at 2.5 times sales until it is profitable.

Clover Health's Q2 Gains Are Outweighed by Its Steeper Losses

Bottom line: skip out on CLOV stock, and stick with the Reddit favorites stronger prospects. The post Clover Stock Has Limited Rebound Potential, So Stay Away appeared first on InvestorPlace.

Clover Stock Has Limited Rebound Potential, So Stay Away

CLOV stock will continue to fade lower as operating costs rise and the digital transformation is anything but proven. The post Avoid Clover Health Stock As Its Losses Mount appeared first on InvestorPlace.

News for Clover Health Investments Stock (CLOV)